29.12.2021 Views

Diagnostic ultrasound ( PDFDrive )

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

1094 PART IV Obstetric and Fetal Sonography

A

B

FIG. 31.4 First-Trimester Nasal Bone Assessment. (A) Midsagittal proile of a fetus shows the correct method of assessing the nasal bone.

Note that the nasal bone is more echogenic than the overlying skin and they form an equal (=) sign. (B) Midsagittal proile of a fetus with trisomy

21 shows the echogenic overlying skin but absent nasal bone. See also Video 31.3.

Criteria for Nasal Bone (NB) Evaluation

ALARA: Thermal Index BONE < 0.7 40

Margins of fetal anatomy clear without ambiguity in nasal

anatomy

Fetus in midsagittal plane

Fetal spine midsagittal in thoracic and cervical region

Tip of nose clearly seen in proile and the skin edge

over the nasal bridge is identiied

Care must be taken to demonstrate the skin edge

separately from the NB so that an equal (=) sign is

apparent

Third and fourth ventricle are identiied in the brain

Fetus occupies majority of image

Head, neck, and upper thorax ill image

Fetus occupies more than 50% of width and length of

image

Angle of insonation 45 degrees to fetal proile,

perpendicular to NB

Echogenicity of NB is comparable to other bony structures

and similar or brighter than the overlying skin.

Nonvisualization of the nasal bone increases with thickened

NT measurements. In fetuses with an NT below the 95th percentile,

1.6% had a nonvisualized nasal bone, compared with

2.7% for NT above the 95th percentile of 3.4 mm, 5.4% for NT

3.5 to 4.4 mm, 6% for NT 4.5 to 5.4 mm, and 15% for NT of

5.5 mm or greater. In this same study, an absent nasal bone was

seen in 69% of trisomy 21 fetuses and in 32% of fetuses with

other chromosomal defects. 54

No signiicant association exists between the biochemical

markers free β-hCG and PAPP-A and the fetal nasal bone;

therefore these can be combined to reine the irst-trimester

risk assessment for trisomy 21. 55 Cicero et al. 56 prospectively

evaluated 20,418 singleton fetuses between 11 and 14 weeks.

he fetal nasal bone was absent in 238 (1.2%), was present in

19,937 (97.6%), and could not be evaluated in 243 (1.2%). A

fetal nasal bone was absent in 113 in 20,165 (0.6%) of chromosomally

normal fetuses and in 87 in 140 (62.1%) of fetuses with

trisomy 21. he combination of NT and biochemical markers

in the irst trimester (combined irst-trimester screening) resulted

in the identiication of 90% of fetuses with trisomy 21 at an FPR

of 5%. Inclusion of the nasal bone resulted in the same rate of

detection of trisomy 21 but with the FPR decreasing to 2.5%.

hese statistics held true if all fetuses underwent screening with

a nasal bone evaluation performed at the time the NT was

measured or if the nasal bone was evaluated in a two-stage

approach in which only those at intermediate risk based on

combined screening results underwent nasal bone evaluation.

Orlandi et al. 57 used a simpliied method for assessing the presence

or absence of the nasal bone in which the nasal bone was

considered absent only if there was no line below the nasal bridge

at all. hey found that using this strategy resulted in fewer cases

being classiied as absent while maintaining a high detection

rate for aneuploidy.

Not all investigators have been as successful using the fetal

nasal bone to assess for aneuploidy. Sepulveda et al. 58 reported

on 1287 consecutive fetuses being evaluated for NT and presence

or absence of a nasal bone. Overall, 110 fetuses (8.5%) had an

NT at or above 95% and 25 (1.9%) had an absent nasal bone.

Of the 31 trisomy 21 fetuses, 28 had an NT above 95% and 13

had an absent nasal bone. he detection rate of trisomy 21 was

90.3% using NT and 41.9% using an absent nasal bone. All but

one fetus with an absent nasal bone had a thickened NT, and

only two normal fetuses had an absent nasal bone. hese authors

concluded that although an absent nasal bone is highly predictive

of trisomy 21, it is less useful as a sonographic marker than the

NT. Malone et al. 59 reported that the nasal bone evaluation was

not a useful test for population screening.

It is evident that the issues surrounding nasal bone screening

in the irst trimester are complex. he identiication of the nasal

bone as present or absent is a specialized skill that is attained

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!